Connection

Jacques Izopet to Anti-HIV Agents

Back to Details
This is a "connection" page, showing publications Jacques Izopet has written about Anti-HIV Agents.
Jacques Izopet
Connection Strength
0.427
Anti-HIV Agents
  1. HIV-1-resistant strains during 8-week on 8-week off intermittent therapy and their effect on CD4+ T-cell counts and antiviral response. Antivir Ther. 2008; 13(4):537-45.
    View in: PubMed
    Score: 0.142
  2. Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France. J Antimicrob Chemother. 2019 05 01; 74(5):1417-1424.
    View in: PubMed
    Score: 0.078
  3. Ultrasensitive Human Immunodeficiency Virus Type 1 Viral Load as a Marker of Treatment Choice for Simplification Strategies. Clin Infect Dis. 2018 11 28; 67(12):1883-1889.
    View in: PubMed
    Score: 0.076
  4. Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study. J Antimicrob Chemother. 2017 06 01; 72(6):1769-1773.
    View in: PubMed
    Score: 0.068
  5. CCR6(-) regulatory T cells blunt the restoration of gut Th17 cells along the CCR6-CCL20 axis in treated HIV-1-infected individuals. Mucosal Immunol. 2016 09; 9(5):1137-50.
    View in: PubMed
    Score: 0.062
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.